
Stoke Therapeutics, Inc.
Stoke Therapeutics, Inc. (STOK) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · STOK · as of Jun 8, 2026
Key Statistics
Explore Stoke Therapeutics, Inc. Data
stok stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 15 · Buy rate: 80.0%
The STOK analyst consensus is Buy, based on ratings from 15 Wall Street analysts over the past 3 months. The average 12-month price target is $43.86, representing +49.37% upside from the current price of $29.36.
Competitors & Peers
stok competitorsStock Performance
Full HistoryAbout Stoke Therapeutics, Inc.
Stoke Therapeutics, Inc. an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United Sta…
what is stoke therapeutics, inc. · stok stock overview · stoke therapeutics, inc. company profile · who is stoke therapeutics, inc. ceo · stok NASDAQ · stoke therapeutics, inc. headquarters · stoke therapeutics, inc. business segments
About Stock Overview & Key Data
Stoke Therapeutics, Inc. (STOK) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jun 19, 2019. As of the latest trading session, STOK stock price is $29.36, with a market capitalization of $1.8B. The stock has returned +161.55% over the past 12 months and -8.29% year-to-date.
According to 15 Wall Street analysts, the consensus rating for Stoke Therapeutics, Inc. stock is Buy, with an average 12-month price target of $43.86. In fiscal year 2025, Stoke Therapeutics, Inc. reported revenue of $184.4M and net income of -$6.9M. For detailed data — including Stoke Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Stoke Therapeutics, Inc. (STOK) stock price is $29.36. The stock is traded on NASDAQ under the ticker symbol STOK. The 52-week range is $10.63 – $40.22.